CA2388912A1 - 6 human secreted proteins - Google Patents

6 human secreted proteins Download PDF

Info

Publication number
CA2388912A1
CA2388912A1 CA002388912A CA2388912A CA2388912A1 CA 2388912 A1 CA2388912 A1 CA 2388912A1 CA 002388912 A CA002388912 A CA 002388912A CA 2388912 A CA2388912 A CA 2388912A CA 2388912 A1 CA2388912 A1 CA 2388912A1
Authority
CA
Canada
Prior art keywords
polypeptide
seq
sequence
polynucleotide
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002388912A
Other languages
English (en)
French (fr)
Inventor
Steven M. Ruben
George A. Komatsoulis
Jian Ni
Daniel R. Soppet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2388912A1 publication Critical patent/CA2388912A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002388912A 1999-11-12 2000-11-08 6 human secreted proteins Abandoned CA2388912A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16473199P 1999-11-12 1999-11-12
US60/164,731 1999-11-12
US21513200P 2000-06-30 2000-06-30
US60/215,132 2000-06-30
PCT/US2000/030657 WO2001034799A1 (en) 1999-11-12 2000-11-08 6 human secreted proteins

Publications (1)

Publication Number Publication Date
CA2388912A1 true CA2388912A1 (en) 2001-05-17

Family

ID=26860801

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002388912A Abandoned CA2388912A1 (en) 1999-11-12 2000-11-08 6 human secreted proteins

Country Status (5)

Country Link
EP (1) EP1235907A4 (de)
JP (1) JP2003513668A (de)
AU (1) AU1473801A (de)
CA (1) CA2388912A1 (de)
WO (1) WO2001034799A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008010980A2 (en) * 2006-07-14 2008-01-24 Thallion Pharmaceuticals Incorporated Tat-049 and methods of assessing and treating cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580753A (en) * 1989-05-23 1996-12-03 Ludwig Institute For Cancer Research DNA encoding the human cytokine, interleukin-9
ES2240981T3 (es) * 1994-12-06 2005-10-16 Immunex Corporation Citocina denominada lerk-7.
US5707829A (en) * 1995-08-11 1998-01-13 Genetics Institute, Inc. DNA sequences and secreted proteins encoded thereby
DE69835751T2 (de) * 1997-08-01 2007-10-04 Serono Genetics Institute S.A. 5' ests für proteine, die nicht gewebespezifisch sind
JP2002543785A (ja) * 1999-05-11 2002-12-24 インサイト・ゲノミックス・インコーポレイテッド 細胞外マトリックス及び接着関連タンパク質
EP1683811B1 (de) * 1999-06-09 2009-08-19 Genentech, Inc. Methoden zur Diagnose von Tumoren
WO2001005803A1 (en) * 1999-07-16 2001-01-25 Gene Logic, Inc. NOVEL cDNAs ASSOCIATED WITH RENAL DISEASE

Also Published As

Publication number Publication date
JP2003513668A (ja) 2003-04-15
EP1235907A4 (de) 2003-07-30
EP1235907A1 (de) 2002-09-04
WO2001034799A1 (en) 2001-05-17
AU1473801A (en) 2001-06-06

Similar Documents

Publication Publication Date Title
CA2387959A1 (en) 21 human secreted proteins
CA2368068A1 (en) 27 human secreted proteins
CA2388822A1 (en) 27 human secreted proteins
CA2388777A1 (en) 18 human secreted proteins
CA2385475A1 (en) 18 human secreted proteins
CA2387799A1 (en) 19 human secreted proteins
CA2403508A1 (en) Extracellular matrix polynucleotides, polypeptides, and antibodies
CA2389916A1 (en) B7-like polynucleotides, polypeptides, and antibodies
CA2400638A1 (en) 7 human ovarian and ovarian cancer associated proteins
CA2388922A1 (en) 23 human secreted proteins
CA2386641A1 (en) 32 human secreted proteins
CA2385431A1 (en) Tgf-beta receptor polynucleotides, polypeptides, and antibodies
CA2382729A1 (en) 29 human cancer associated proteins
US20030028008A1 (en) Seven transmembrane receptor polynucleotides, polypeptides, and antibodies
CA2382148A1 (en) 25 human secreted proteins
US20030050466A1 (en) TM4SF polynucleotides, polypeptides, and antibodies
CA2365522A1 (en) 48 human secreted proteins
CA2403901A1 (en) 29 human secreted proteins
CA2385169A1 (en) 43 human secreted proteins
CA2399943A1 (en) Immune system-related polynucleotides, polypeptides, and antibodies
CA2418676A1 (en) 21 human secreted proteins
US20050244845A1 (en) 90 human secreted proteins
CA2382161A1 (en) Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies
CA2387261A1 (en) 25 human secreted proteins
CA2478313A1 (en) 41 human secreted proteins

Legal Events

Date Code Title Description
FZDE Dead